Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment

AIM: 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) is valuable in the management of patients with oesophageal cancer, but a role in gastric cancer staging is debated. Our aim was to review the role of FDG PET-CT in a large gastric cancer cohort in a tertiary UK...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch, Karen D., Chicklore, Sugama, Cook, Gary J., Davies, Andrew R., Kelly, Mark, Gossage, James A., Baker, Cara R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075833/
https://www.ncbi.nlm.nih.gov/pubmed/31377821
http://dx.doi.org/10.1007/s00259-019-04429-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075833/
https://www.ncbi.nlm.nih.gov/pubmed/31377821
http://dx.doi.org/10.1007/s00259-019-04429-x

Ejemplares similares